Newsroom

Newsroom

Real-world PD-L1 test utilization and analytical concordance of the PD-L1 IHC 28-8 and 22C3 assays in patients with breast cancer

Literature
Read More

Circulating tumor DNA (ctDNA) clearance as a biomarker in patients with locally advanced NSCLC following chemoradiation

Literature
Read More

Why does IHC remain so popular for CDx development?

Blog
Read More

New China operation

Blog
Read More

NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

Press Release
Read More

NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes

Press Release
Read More

CRO and Clinical Reference Laboratory Commercial Incentives

Blog
Read More

NeoGenomics To Virtually Participate In The 39th Annual J.P. Morgan Healthcare Conference

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients